| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |